Tempus AI Genetic Information Privacy Class Action

Tempus AI is facing proposed class action litigation alleging that, after acquiring Ambry Genetics in 2025, it transferred patients’ sensitive genetic information to train artificial intelligence models without consent. The lawsuit seeks damages and an injunction against further allegedly unauthorized use, transfer, disclosure, or commercialization of the genetic information; the current procedural stage beyond the proposed filing is not specified.